In a landscape where rare diseases often linger in the shadows of medical research, autosomal dominant hypocalcemia Type 1 (AD#), a condition affecting calcium regulation, impacts thousands with limited treatment options. With an estimated 12,000 individuals in the U.S. grappling with this
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research and development, coupled with a keen understanding of technology and innovation, makes him a leading voice in the industry. Today, we’re diving into the FDA’s recent push to accelerate
Imagine a world where the simple act of choosing what’s on your dinner plate could slow the devastating effects of climate change and shield millions from life-threatening diseases, while also reshaping global health and sustainability. As global meat consumption surges, with projections estimating
What if a disease as deadly as pancreatic cancer, known for its stubborn return even after grueling treatments, could be tamed by a single, precise strike during surgery? At Johns Hopkins Kimmel Cancer Center, a groundbreaking approach using intraoperative radiation therapy (IORT) has slashed local
As modern life pulls us further from our natural rhythms, the consequences for our health are becoming clearer. I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, particularly in the intersection of technology and health
In an era where cognitive health is becoming a pressing global concern, with neurodegenerative diseases like Alzheimer’s affecting millions and driving demand for preventative solutions, a natural compound from olives—hydroxytyrosol (HXT)—is emerging as a game-changer in the industry. This market
